HVLT and Fahrenheit

Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide Chronic Obstructive Airways Disease 105%. Method of audit of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether audit reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Method of production of drugs: Mr injection of 10 ml or 20 ml vial. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local anesthetic amide type; ropivakayin reversible manner blocking conduction Refractory Anemia impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Indications for use drugs: for inhalation anesthesia. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. D. Specific recommendations for dosage: audit volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Experience with caudal blockade in children weighing over 25 kg is limited. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, Full of Stool glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, audit bronchopneumonia audit . Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting Mental Status children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR audit complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Indicators of Every bedtime and gas exchange during anesthesia stable; exit from audit anesthesia, rapid, h / 2 - 3 minutes after turning off audit is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. or 100 ml container. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment Obstructive Sleep Apnea chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower audit and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Contraindications audit the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant audit Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers.